Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지

The Role of B-type Natriuretic Peptide in Predicting Postoperative Complications and Outcomes in Patients Undergoing Coronary Artery Bypass Graft

관상동맥 우회술 환자의 술 후 합병증 예견에 대한 BNP의 역할

  • Jung, Tae-Eun (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Jang-Hoon (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Do, Hyung-Dong (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Han, Sung-Sae (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University) ;
  • Lee, Dong-Hyup (Department of Thoracic and Cardiovascular Surgery, College of Medicine, Yeungnam University)
  • 정태은 (영남대학교 의과대학 흉부외과학교실) ;
  • 이장훈 (영남대학교 의과대학 흉부외과학교실) ;
  • 도형동 (영남대학교 의과대학 흉부외과학교실) ;
  • 한승세 (영남대학교 의과대학 흉부외과학교실) ;
  • 이동협 (영남대학교 의과대학 흉부외과학교실)
  • Published : 2008.02.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Circulating levels of brain natriuretic peptide (BNP) provide prognostic information for patients with heart failure. The aim of our study was to investigate whether preoperative and postoperative BNP levels could predict postoperative complications and outcomes in patients after coronary artery bypass graft (CABG). Material and Method: Data was collected prospectively on 30 patients (M/F=19/11, age $60.0{\pm}9.6$ years) undergoing conventional CABG during a 1-year period beginning on January 1, 2005. Patients underwent off-pump CABG, and combined surgery was excluded. The BNP assay was performed preoperatively, immediate postoperatively at the intensive care unit (ICU), and 1, 3, 5, and 7days postoperatively. Result: Preoperative BNP levels significantly correlated with preoperative echocardiographic ejection fraction and an ICU stay of 5 days or more (r=-0.4, p=0.028; r=0.39, p=0.031, respectively). A preoperative BNP cut-off value above 263 pg/mL demonstrated high specificity (90.5%) for predicting postoperative complications using the receiver operating characteristics curves. Preoperative and postoperative (7 days) BNP levels were different depending on the abscence (mean BNP=$99{\pm}23\;pg/mL$ vs. $296{\pm}74\;pg/mL$, p<0.05) and presence (mean BNP=$212{\pm}29\;pg/mL$ vs. $408{\pm}23\;pg/mL$, p<0.01). Conclusion: Preoperative BNP levels >263 pg/mL predict postoperative complications in patients receiving CABG.

배경: 혈 중 BNP 수치는 심부전 환자의 예후에 정보를 제공한다고 잘 알려져 있다. 이 연구의 목적은 술 전과 술 후 BNP 수치가 관상동맥 수술한 환자의 술 후 합병증 및 결과를 예견하는 데 사용될 수 있는지 알아보고자 조사하였다. 대상 및 방법: 2005년 1월 1일부터 1년간 심폐기를 사용한 관상동맥 환자 30명을 전향적으로 자료 수집하였다(남/여=19/11, 평균 나이 $60{\pm}9.6$세). 심폐기를 사용하지 않고 관상동맥우회수술을 한 경우와 동시에 판막 수술을 시행한 경우는 대상에서 제외하였다. BNP 측정은 술 전, 수슬 직 후, 및 술 후 1, 3, 5, 7일째 혈액 채취를 하여 검사하였다. 결과: 술 전 BNP 수치와 술 전 초음파를 통한 심장 구혈률(r=-0.4, p=0.028)과 중환자실에서 5일 이상 치료한 경우(r=0.39, p=0.031)는 통계학적인 의미가 있었다. Receiver operating characteristics (ROC) curve를 사용하여 술 전 BNP 수치가 술 후 합병증을 예견하는 cut-off치는 특이도 90.5%에서 263 pg/mL이었다. 슬 후 합병증이 없는 군과 발생한 군 사이에서 BNP 수치의 변화를 보면 술 전 BNP 수치(평균 BNP=$99{\pm}23\;pg/mL$ vs $296{\pm}74\;pg/mL$, p<0.05)와 술 후 7일째 BNP 수치(평균 $212{\pm}29\;pg/mL$ vs $408{\pm}23\;pg/mL$, p<0.01)에서 통계학적으로 의미 있게 차이가 있었다. 결론: 술 전 BNP 수치가 263 pg/mL 이상이면 술 후 합병증을 예견할 수 있다. BNP 수치는 관상동맥우회술 환자의 술 후 합병증의 가능성을 예견하는 유용한 지표로서 사용될 수 있다.

Keywords

References

  1. Mair J, Friedl W, Thomas S, Puschendorf B. Natriuretic peptides in assessment of left-ventricular dysfuntion. Scand J Clin Lab Invest Suppl 1999;230:132-42
  2. Struthers AD. Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use? BMJ 1994;308:1615-9
  3. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel AS. Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39:202-9
  4. Hutfless R, Kazanegra R, Madani M, et al. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004;43:1873-9 https://doi.org/10.1016/j.jacc.2003.12.048
  5. Shirasawa B, Hamano K, Kawamura T, et al. Does the serum brain natriuretic peptide level after open heart surgery reflect myocardial protection? Kyobu Geka 2000;53:123-6
  6. Chello M, Mastroroberto P, Perticone F, et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiothorac Surg 2001;20:140-6 https://doi.org/10.1016/S1010-7940(01)00754-0
  7. Kang DH, Kim MJ, Kang SJ, et al. Role of B-type natriuretic peptide in diagnosis and follow-up of diastolic heart failure. Korean Circ J 2006;36:359-65 https://doi.org/10.4070/kcj.2006.36.5.359
  8. Higgins TL, Estafanous FG, Loop FD, Beck GJ, Blum JM, Paranandi L. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA 1992;267:2344-8 https://doi.org/10.1001/jama.267.17.2344
  9. Weightman WM, Gibbs NM, Sheminant NR, Thackray NM, Newman AJ. Risk prediction in coronary artery surgery: a comparison of four risk scores. Med J Aust 1997;166:408-11
  10. Shimizu H, Masuta K, Aono K, et al. Molecular forms of human brain natriuretic peptide in plasma. Clin Chim Acta 2002;316:129-35 https://doi.org/10.1016/S0009-8981(01)00745-8
  11. Stein BC, Levin RI. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J 1998;135:914-23 https://doi.org/10.1016/S0002-8703(98)70054-7
  12. Kohno M, Hario T, Yokokawa K, et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 1992;92:29-34 https://doi.org/10.1016/0002-9343(92)90011-Y
  13. Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med 2002;39:131-8 https://doi.org/10.1067/mem.2002.121483
  14. Cheng V, Kazanegra R, Garcia A, et al. A rapid bedside test for peptide (BNP) predicts treatment outcomes in patients admitted for decompensated heart failure. J Am Coll Cardiol 2001;37:386-91 https://doi.org/10.1016/S0735-1097(00)01157-8
  15. Bettencourt P, Ferreira S, Azevedo A, Ferreira A. Preliminary data on the potential usefulness of B-type natriuretic peptide levels in predicting outcome after hospital discharge in patients with heart failure. Am J Med 2002;113:215-9 https://doi.org/10.1016/S0002-9343(02)01184-1
  16. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic valve of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014- 21 https://doi.org/10.1056/NEJMoa011053
  17. Kikuta K, Yasue H, Yoshimura M, et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 1996;132:101-7 https://doi.org/10.1016/S0002-8703(96)90396-8
  18. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery predictors, outcomes, and resoruce utillization. JAMA 1996;276:300-6 https://doi.org/10.1001/jama.276.4.300
  19. Palazzuoli A, Carrera A, Calabria P, et al. Brain natriuretic peptide levels during cardiac reperfusion: comparison between percutaneous coronary angioplasty and aorto-coronaric bypass. Clin Chim Acta 2004;342:87-92 https://doi.org/10.1016/j.cccn.2003.11.021